<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> is characterized by the presence of a port-wine <z:hpo ids='HP_0003764'>nevus</z:hpo>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e>, <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo>, <z:hpo ids='HP_0002315'>headache</z:hpo>, and <z:hpo ids='HP_0001263'>developmental delay</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We studied 20 cases to test the hypothesis that decreased cerebral blood flow alters neurologic function by affecting cellular <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism </plain></SENT>
<SENT sid="2" pm="."><plain>Group A consisted of 10 patients with a mean age of 1.75 years and early <z:hpo ids='HP_0001250'>seizure</z:hpo> <z:hpo ids='HP_0003674'>onset</z:hpo> (6.8 months), whereas group B was composed of older patients (mean age, 15.3 years) with later <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:hpo ids='HP_0001250'>seizures</z:hpo> (3.7 years) </plain></SENT>
<SENT sid="3" pm="."><plain>Neurologic disease was more severe in group A, but group B had more widespread structural brain defects - shown on computed tomographic scans and magnetic resonance imaging - and metabolic brain defects shown on hexamethylpropyleneamine <z:chebi fb="0" ids="25750">oxime</z:chebi> and <z:chebi fb="0" ids="36939">[18F]</z:chebi> fluorodeoxyglucose single <z:chebi fb="23" ids="30212">photon</z:chebi> emission computed tomographic scans </plain></SENT>
<SENT sid="4" pm="."><plain>Six group A cases had hypoperfusion at baseline and five of nine had worsening of perfusion and <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism 1 year later </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 119 <z:hpo ids='HP_0002401'>stroke-like episodes</z:hpo> occurred in six group A cases and eight group B cases; there were 65% fewer <z:hpo ids='HP_0001297'>strokes</z:hpo> in children treated with aspirin </plain></SENT>
<SENT sid="6" pm="."><plain>The data suggest that progressive hypoperfusion and <z:chebi fb="105" ids="17234">glucose</z:chebi> hypometabolism are associated with <z:hpo ids='HP_0002344'>neurologic deterioration</z:hpo> in <z:e sem="disease" ids="C0038505" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="PKWS">Sturge-Weber syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Longitudinal studies are needed to better define the natural history of disease and to evaluate the safety and efficacy of aspirin therapy </plain></SENT>
</text></document>